These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 29206905)
1. Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis. Runge TM; Eluri S; Woosley JT; Shaheen NJ; Dellon ES Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 29206905 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype. Runge TM; Eluri S; Cotton CC; Burk CM; Woosley JT; Shaheen NJ; Dellon ES Am J Gastroenterol; 2016 Feb; 111(2):206-13. PubMed ID: 26753894 [TBL] [Abstract][Full Text] [Related]
3. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis. Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866 [TBL] [Abstract][Full Text] [Related]
4. Recent insights on the use of topical steroids in eosinophilic esophagitis. Reddy A; Ashat D; Murali AR Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417 [TBL] [Abstract][Full Text] [Related]
5. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis. Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220 [TBL] [Abstract][Full Text] [Related]
6. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis. Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670 [TBL] [Abstract][Full Text] [Related]
7. Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis. Eluri S; Selitsky SR; Perjar I; Hollyfield J; Betancourt R; Randall C; Rusin S; Woosley JT; Shaheen NJ; Dellon ES Clin Gastroenterol Hepatol; 2019 May; 17(6):1081-1088.e2. PubMed ID: 30213583 [TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia. Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589 [TBL] [Abstract][Full Text] [Related]
16. Distal esophagus is the most commonly involved site for strictures in patients with eosinophilic esophagitis. Eluri S; Tappata M; Huang KZ; Koutlas NT; Robey BS; Fan C; Reed CC; Shaheen NJ; Dellon ES Dis Esophagus; 2020 Mar; 33(2):. PubMed ID: 31778150 [TBL] [Abstract][Full Text] [Related]
17. The natural history of steroid-naïve eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years. Lipka S; Keshishian J; Boyce HW; Estores D; Richter JE Gastrointest Endosc; 2014 Oct; 80(4):592-598. PubMed ID: 24703087 [TBL] [Abstract][Full Text] [Related]
18. The esophageal biopsy "pull" sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video). Dellon ES; Gebhart JH; Higgins LL; Hathorn KE; Woosley JT; Shaheen NJ Gastrointest Endosc; 2016 Jan; 83(1):92-100. PubMed ID: 26142556 [TBL] [Abstract][Full Text] [Related]
19. Association Between Body Mass Index and Clinical and Endoscopic Features of Eosinophilic Esophagitis. Wolf WA; Piazza NA; Gebhart JH; Rusin S; Covey S; Higgins LL; Beitia R; Speck O; Woodward K; Cotton CC; Runge TM; Eluri S; Woosley JT; Shaheen NJ; Dellon ES Dig Dis Sci; 2017 Jan; 62(1):143-149. PubMed ID: 27778205 [TBL] [Abstract][Full Text] [Related]
20. The safety of a strict wire-guided dilation protocol for eosinophilic esophagitis. Saligram S; McGrath K Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):699-703. PubMed ID: 24901815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]